Wheezo from Respiri set to go on sale.

Respiri Limited (ASX:RSH) has achieved TGA approval to list its wheezo asthma monitoring device (pictured) on the Australian Therapeutics Goods Register (ARTG). The device is the world’s first digital wheeze monitoring solution of sensor, smartphone application and digital health platform to help people manage respiratory disease. TGA approval came after the Melbourne company undertook an…

A once in a generation funding opportunity: monetary policies open doors to global funding opportunities

Treasurer Josh Frydenburg’s message to business is “to back yourself and use your balance sheet to invest and grow.” Whilst we may not agree with all his policies, it is clear there is a significant need to invest in R&D, innovation and ways to enhance productivity, whether that’s through new technologies or processes to improve performance.